Audentes Therapeutics, Inc. Total Liabilities and Equity
Audentes Therapeutics, Inc. had Total Liabilities and Equity of $441.51 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2019-11-07
- 2019-09-30: Liabilities and Equity $441.51M.
- 2019-06-30: Liabilities and Equity $478.11M.
- 2019-03-31: Liabilities and Equity $455.18M.
- 2018-12-31: Liabilities and Equity $472.56M.
| Period end | Liabilities and Equity |
|---|---|
| 2019-09-30 | $441.51M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $478.11M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $455.18M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $472.56M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $337.77M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $366.05M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $373.09M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $178.66M 10-K · filed 2019-03-01 |
| 2017-09-30 | $200.25M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $188.59M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $121.74M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $142.06M 10-K · filed 2018-03-09 |
| 2016-09-30 | $158.75M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $100.53M 10-Q · filed 2016-09-01 |
| 2015-12-31 | $117.47M 10-K · filed 2017-03-13 |